DE69603613T2 - 4-(cycloalkyl)piperidine und 4-(cycloalkylalkyl)-piperidine, ihre herstellung und therapeutische verwendung - Google Patents

4-(cycloalkyl)piperidine und 4-(cycloalkylalkyl)-piperidine, ihre herstellung und therapeutische verwendung

Info

Publication number
DE69603613T2
DE69603613T2 DE69603613T DE69603613T DE69603613T2 DE 69603613 T2 DE69603613 T2 DE 69603613T2 DE 69603613 T DE69603613 T DE 69603613T DE 69603613 T DE69603613 T DE 69603613T DE 69603613 T2 DE69603613 T2 DE 69603613T2
Authority
DE
Germany
Prior art keywords
piperidine
cycloalkylalkyl
cycloalkyl
production
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69603613T
Other languages
English (en)
Other versions
DE69603613D1 (de
Inventor
Patrick Lardenois
Jonathan Frost
Patrick Pasau
Pascal George
Maria RENONES
Regine Bartsch
Wai-Tak Li
Pascale Magat
Regis Dupont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510513A external-priority patent/FR2738566B1/fr
Priority claimed from FR9510512A external-priority patent/FR2738568B1/fr
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of DE69603613D1 publication Critical patent/DE69603613D1/de
Publication of DE69603613T2 publication Critical patent/DE69603613T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
DE69603613T 1995-09-08 1996-09-05 4-(cycloalkyl)piperidine und 4-(cycloalkylalkyl)-piperidine, ihre herstellung und therapeutische verwendung Expired - Fee Related DE69603613T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510513A FR2738566B1 (fr) 1995-09-08 1995-09-08 Derives de 4-(cycloalkyl)piperidines et de 4-(cycloalkylalkyl)piperidines, leur preparation et leur application en therapeutique
FR9510512A FR2738568B1 (fr) 1995-09-08 1995-09-08 Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique
PCT/FR1996/001362 WO1997009309A1 (fr) 1995-09-08 1996-09-05 Derives de 4-(cycloalkyl)piperidines et de 4-(cycloalkylalkyl)pi peridines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
DE69603613D1 DE69603613D1 (de) 1999-09-09
DE69603613T2 true DE69603613T2 (de) 2000-03-02

Family

ID=26232195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69603613T Expired - Fee Related DE69603613T2 (de) 1995-09-08 1996-09-05 4-(cycloalkyl)piperidine und 4-(cycloalkylalkyl)-piperidine, ihre herstellung und therapeutische verwendung

Country Status (25)

Country Link
EP (1) EP0848707B1 (de)
JP (1) JPH11514975A (de)
KR (1) KR19990044479A (de)
CN (1) CN1201453A (de)
AR (1) AR003530A1 (de)
AT (1) ATE182885T1 (de)
AU (1) AU703776B2 (de)
BG (1) BG102282A (de)
BR (1) BR9610408A (de)
CA (1) CA2231326A1 (de)
CO (1) CO4750660A1 (de)
CZ (1) CZ66598A3 (de)
DE (1) DE69603613T2 (de)
EE (1) EE9800064A (de)
ES (1) ES2137015T3 (de)
GR (1) GR3031513T3 (de)
HU (1) HUP9802938A2 (de)
IL (1) IL123557A0 (de)
NO (1) NO981000L (de)
NZ (1) NZ316981A (de)
PL (1) PL325421A1 (de)
SI (1) SI0848707T1 (de)
SK (1) SK31198A3 (de)
TR (1) TR199800407T1 (de)
WO (1) WO1997009309A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380261B1 (en) 1997-06-30 2002-04-30 Allergan Sales, Inc. Calcium blockers to treat proliferative vitreoretinopathy
CN1324240A (zh) 1998-10-27 2001-11-28 阿尔康制药厂 外视网膜疾病的治疗
ES2557810T3 (es) * 2004-06-04 2016-01-28 Washington University Métodos y composiciones para tratar neuropatías

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028366A (en) * 1975-01-20 1977-06-07 Sterling Drug Inc. 2-Naphthyl-lower-alkanoylamines
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
FR2684379B1 (fr) * 1991-12-02 1995-04-28 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
WO1994018172A1 (en) * 1993-02-01 1994-08-18 Yoshitomi Pharmaceutical Industries, Ltd. Imidazolylbenzene compound and use thereof as medicine

Also Published As

Publication number Publication date
SK31198A3 (en) 1998-08-05
CO4750660A1 (es) 1999-03-31
IL123557A0 (en) 1998-10-30
AU703776B2 (en) 1999-04-01
BR9610408A (pt) 1999-07-06
AR003530A1 (es) 1998-08-05
EE9800064A (et) 1998-08-17
CN1201453A (zh) 1998-12-09
NO981000D0 (no) 1998-03-06
DE69603613D1 (de) 1999-09-09
BG102282A (en) 1998-09-30
CA2231326A1 (en) 1997-03-13
ATE182885T1 (de) 1999-08-15
ES2137015T3 (es) 1999-12-01
TR199800407T1 (xx) 1998-05-21
WO1997009309A1 (fr) 1997-03-13
HUP9802938A2 (hu) 1999-10-28
JPH11514975A (ja) 1999-12-21
EP0848707A1 (de) 1998-06-24
EP0848707B1 (de) 1999-08-04
NO981000L (no) 1998-05-08
GR3031513T3 (en) 2000-01-31
SI0848707T1 (en) 2000-02-29
MX9801838A (es) 1998-08-30
NZ316981A (en) 1998-12-23
PL325421A1 (en) 1998-07-20
AU6934496A (en) 1997-03-27
KR19990044479A (ko) 1999-06-25
CZ66598A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
DE60009663D1 (de) Piperidin-, tetrahydropyridin- und piperazin-derivate, ihre herstellung und anwendung
DE69019550T2 (de) Piperidin-Derivate, ihre Herstellung und ihre Verwendung.
DE60038200D1 (de) ren Herstellung und Verwendung
ATE173255T1 (de) 3-(5-tetrazolyl-benzyl) aminopiperidin-derivate und tachykinin antagonisten
ATE239693T1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE69332898D1 (de) 4-Carboxamidopiperidinderivate und ihre Verwendung als Neurokinin Antagonisten
DE69821623D1 (de) Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
DE60103394D1 (de) 4-(2-phenylthiazol-5-yl)1,4-diazabicyclo[3.2.2]nonanederivate, ihre herstellung und therapeutische verwendung
DE59510604D1 (de) UV-Absorber, ihre Herstellung und Verwendung
EE200100498A (et) 1,4-asendatud piperasiin-, 1,4-asendatud piperidiin- ja 1-asendatud 4-alkülidenüülpiperidiinühendidning nende raviotstarbeline kasutamine
NO982712D0 (no) FremgangsmÕter og mellomprodukter for fremstilling av 1-benzyl-4-((5,6-dimetoksy-1-indanon)-2-yl)metylpiperidin
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE69511579T2 (de) Biozide alkohole, ihre herstellung und ihre verwendung
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69630391D1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE69723463D1 (de) Cyclische organoselenderivate, ihre herstellung und verwendung
DE69629454D1 (en) Antipsychotische 4-(1h-indolyl-1-yl)-1-substituierte piperidine derivate
DE59508806D1 (de) UV-Absorber, ihre Herstellung und Verwendung
DE69604071D1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
DE69603613D1 (de) 4-(cycloalkyl)piperidine und 4-(cycloalkylalkyl)-piperidine, ihre herstellung und therapeutische verwendung
NZ306319A (en) 1-alkylphenyl substituted 4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butanol derivatives and medicaments
FI972239A0 (fi) (Tiofen-2-yyli) piperidiini- tai tetrahydropyridiinikarboksamideja
DE69816456D1 (de) Verwendung von 4-substituierten tetrahydropyridinen zur herstellung eines arzneimittels mit wirkung auf tgf-beta-1
DE59606132D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69313168D1 (de) Kristallinische substituierte Stannosilikate, ihre Herstellung und Verwendung

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee